Design, synthesis, and biological evaluation of substituted naphthalene imides and diimides as anticancer agent

J Med Chem. 2009 Dec 10;52(23):7873-7. doi: 10.1021/jm901131m.

Abstract

Naphthalimmide (NI) and 1,4,5,8-naphthalentetracarboxylic diimide (NDI) derivatives were synthesized and evaluated for their antiproliferative activity. NDI derivatives 1-9 were more cytotoxic than the corresponding NI derivatives 10-18. The molecular mechanisms of 1 and 2 were investigated in comparison to mitonafide. They interacted with DNA, were not topoisomerase IIalpha poisons, triggered caspase activation, caused p53 protein accumulation, and down-regulated AKT survival. Furthermore, 1 and 2 caused a decrease of ERK1/2 and, unlike mitonafide, inhibited ERKs phosphorylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / toxicity
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • DNA / metabolism
  • Drug Design
  • Humans
  • Imides / chemistry*
  • Imides / metabolism
  • Imides / pharmacology*
  • Imides / toxicity
  • Naphthalenes / chemistry*
  • Topoisomerase Inhibitors

Substances

  • Antineoplastic Agents
  • Imides
  • Naphthalenes
  • Topoisomerase Inhibitors
  • naphthalene
  • DNA